This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/russia/524234-eu-tourism-excluding-sputnik-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| EU agrees to open up to foreign tourists fully vaccinated against Covid-19, but NOT to those who've had Russia’s Sputnik V jab | EU agrees to open up to foreign tourists fully vaccinated against Covid-19, but NOT to those who've had Russia’s Sputnik V jab |
| (4 months later) | |
| The European Union’s agreed plan to re-open its borders to foreigners who have been fully vaccinated against Covid-19 will exclude those inoculated with Sputnik V, with the bloc leaving the Russian jab off its approved list. | The European Union’s agreed plan to re-open its borders to foreigners who have been fully vaccinated against Covid-19 will exclude those inoculated with Sputnik V, with the bloc leaving the Russian jab off its approved list. |
| On Wednesday, ambassadors representing the EU’s 27 member states reached a consensus that people from outside the union may enter its territory if they have received a vaccine approved by the European Medicines Agency (EMA) or the World Health Organization (WHO). This means that the Western Pfizer-BioNTech, Moderna, Johnson & Johnson and AstraZeneca vaccines, as well as the Chinese Sinopharm jab, will all be accepted. | On Wednesday, ambassadors representing the EU’s 27 member states reached a consensus that people from outside the union may enter its territory if they have received a vaccine approved by the European Medicines Agency (EMA) or the World Health Organization (WHO). This means that the Western Pfizer-BioNTech, Moderna, Johnson & Johnson and AstraZeneca vaccines, as well as the Chinese Sinopharm jab, will all be accepted. |
| Despite beginning a rolling review two months ago, the EMA is yet to register Sputnik V. The decision not to accept the jab could inconvenience Russians who were looking to travel abroad in the summer. | Despite beginning a rolling review two months ago, the EMA is yet to register Sputnik V. The decision not to accept the jab could inconvenience Russians who were looking to travel abroad in the summer. |
| Sputnik V was registered in Russia last year, and thus far has been approved in 66 countries. Two of those nations, Hungary and Slovakia, are actually in the EU, and many other member states have expressed a willingness to buy large batches of doses, including Germany and Austria. | Sputnik V was registered in Russia last year, and thus far has been approved in 66 countries. Two of those nations, Hungary and Slovakia, are actually in the EU, and many other member states have expressed a willingness to buy large batches of doses, including Germany and Austria. |
| However, individual nations within the EU still have the opportunity to make their own rules. Last week, Greek Tourism Minister Harry Theoharis revealed that the country would allow entry to tourists who have received the Russian jab, and that they would face no requirement to quarantine. Bulgaria has already opened its borders to Russians vaccinated with Sputnik V. | However, individual nations within the EU still have the opportunity to make their own rules. Last week, Greek Tourism Minister Harry Theoharis revealed that the country would allow entry to tourists who have received the Russian jab, and that they would face no requirement to quarantine. Bulgaria has already opened its borders to Russians vaccinated with Sputnik V. |
| According to the Russian Direct Investment Fund, which bankrolled its development, Sputnik V has an efficacy rate of 97.6%, based on the analysis of data on the coronavirus infection rate among those in Russia vaccinated with both components. In February, a study published in the British medical journal The Lancet found the jab to have more than 91.6% efficacy. | According to the Russian Direct Investment Fund, which bankrolled its development, Sputnik V has an efficacy rate of 97.6%, based on the analysis of data on the coronavirus infection rate among those in Russia vaccinated with both components. In February, a study published in the British medical journal The Lancet found the jab to have more than 91.6% efficacy. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |